Raw 264.7 Whole Cell - T0901317 treated: Lysates
Treatment with liver X receptor (LXR) agonists like benzenesulfoamide T0901317 [N-(2,2,2-Trifluoroethyl)-N-[4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl]-benzenesulfonamide], or more commonly known as T0901317 (T09), lowers the cholesterol level in serum and liver and inhibits the development of atherosclerosis in murine disease models. T09 modulates cholesterol metabolism and inhibits inflammation.
Show More
1 result for "Raw 264.7 Whole Cell - T0901317 treated Lysates" in Products
1 result for "Raw 264.7 Whole Cell - T0901317 treated Lysates" in Products
Raw 264.7 Whole Cell - T0901317 treated: Lysates
Treatment with liver X receptor (LXR) agonists like benzenesulfoamide T0901317 [N-(2,2,2-Trifluoroethyl)-N-[4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl]-benzenesulfonamide], or more commonly known as T0901317 (T09), lowers the cholesterol level in serum and liver and inhibits the development of atherosclerosis in murine disease models. T09 modulates cholesterol metabolism and inhibits inflammation.
Show More
| Applications: | WB |
![Western Blot: Raw 264.7 Whole CellT0901317 treated Whole Cell Lysate [NBP1-30158]](https://resources.bio-techne.com/images/products/Raw-264.7-Whole-Cell-Lysate-Western-Blot-NBP1-30158-img0003.jpg "Western Blot: Raw 264.7 Whole CellT0901317 treated Whole Cell Lysate [NBP1-30158]")